Bristol-Myers Squibb
BMY
#172
Rank
NZ$229.52 B
Marketcap
NZ$112.29
Share price
1.06%
Change (1 day)
34.09%
Change (1 year)

Bristol-Myers Squibb (BMY) - Total liabilities

Total liabilities on the balance sheet as of September 2026 : NZ$116.87 Billion

According to Bristol-Myers Squibb's latest financial reports the company's total liabilities are NZ$116.87 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Bristol-Myers Squibb - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$103.84 B0.35%
2022-12-31NZ$103.48 B-3.58%
2021-12-31NZ$107.32 B-3.92%
2020-12-31NZ$111.70 B-3.85%
2019-12-31NZ$116.18 B273.61%
2018-12-31NZ$31.09 B1.76%
2017-12-31NZ$30.56 B21.94%
2016-12-31NZ$25.06 B-0.99%
2015-12-31NZ$25.31 B5.68%
2014-12-31NZ$23.95 B-15.73%
2013-12-31NZ$28.42 B5.04%
2012-12-31NZ$27.05 B23.47%
2011-12-31NZ$21.91 B9.51%
2010-12-31NZ$20.01 B-10.41%
2009-12-31NZ$22.33 B-24.98%
2008-12-31NZ$29.77 B46.1%
2007-12-31NZ$20.37 B-7.87%
2006-12-31NZ$22.12 B-10.69%
2005-12-31NZ$24.76 B-12.65%
2004-12-31NZ$28.35 B4.36%
2003-12-31NZ$27.17 B-12.58%
2002-12-31NZ$31.08 B-31.12%
2001-12-31NZ$45.12 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
NZ$207.22 B 77.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$142.29 B 21.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$206.76 B 76.90%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$252.11 B 115.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$192.74 B 64.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$150.10 B 28.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$121.40 B 3.88%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$23.67 B-79.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$157.01 B 34.34%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$117.04 B 0.15%๐Ÿ‡ฌ๐Ÿ‡ง UK